[Federal Register Volume 75, Number 199 (Friday, October 15, 2010)]
[Notices]
[Pages 63491-63492]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-26025]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Basic Science Conference Grant (R13) Review.
    Date: October 27, 2010.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Virtual Meeting).
    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive, Blvd., 
Bethesda, MD 20892-8401, 301-402-6626, <a href="/cdn-cgi/l/email-protection#385f55090c0d5978565150165f574e"><span class="__cf_email__" data-cfemail="deb9b3efeaebbf9eb0b7b6f0b9b1a8">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Treatment and Services Use.
    Date: October 28, 2010.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard, 
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Jose F. Ruiz, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive, Blvd., 
Bethesda, MD 20892, 301-451-3086, <a href="/cdn-cgi/l/email-protection#8ffdfae6f5e5e9cfe1e6ebeea1e1e6e7a1e8e0f9"><span class="__cf_email__" data-cfemail="e09295899a8a86a08e898481ce8e8988ce878f96">[email protected]</span></a>.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, NIDA-K Conflicts Special Emphasis Panel.
    Date: November 3, 2010.
    Time: 5:30 p.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel, 1150 22nd Street, NW., Washington, DC 
20037.
    Contact Person: Eliane Lazar-Wesley, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive, 
Boulevard, Bethesda, MD 20892-8401, 301-451-4530, 
<a href="/cdn-cgi/l/email-protection#046168657e65767361446a6d60652a6a6d6c2a636b72"><span class="__cf_email__" data-cfemail="20454c415a41525745604e4944410e4e49480e474f56">[email protected]</span></a>.
    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Research Education and Science Education 
Program Review (R25).
    Date: November 10, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Ave., NW., Washington, 
DC 20037.

[[Page 63492]]

    Contact Person: Gerald L. McLaughlin, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive, Blvd., 
Bethesda, MD 20892-8401, 301-402-6626, <a href="/cdn-cgi/l/email-protection#93f4fea2a7a6f2d3fdfafbbdf4fce5"><span class="__cf_email__" data-cfemail="a6c1cb979293c7e6c8cfce88c1c9d0">[email protected]</span></a>.
    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, P50 Centers Review.
    Date: February 22-25, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road, NW., Washington, DC 20015.
    Contact Person: Eliane Lazar-Wesley, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, 
Bethesda, MD 20892-8401, 301-451-4530, <a href="/cdn-cgi/l/email-protection#4a2f262b302b383d2f0a24232e2b64242322642d253c"><span class="__cf_email__" data-cfemail="3d58515c475c4f4a587d5354595c13535455135a524b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: October 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-26025 Filed 10-14-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>